Amoxil (amoxicillin) is a semisynthetic penicillin antibiotic supplied as capsules, powder for oral suspension, tablets and injection, and the dry presentations need no refrigerated cold chain.

We do not publish prices. The landed cost for an importer depends on whether you want the Amoxil name or an Indian-made line, the strength and form, the pack, the quantity, the registration route in your destination and Incoterms. Dry capsules need no refrigerated cold chain, though the UK label limits storage to 25 degrees C, which shapes the freight lane. The UK 500 mg capsule SmPC we fetched lists packs of 15, 20, 21, 100, 500 and 1000 capsules, so a 20-capsule pack is a normal line, though the SmPC notes not every pack is marketed. M Care Exports quotes per destination once you send the strength, pack, volume and country.

The EMA Article 30 referral annex lists Amoxil-named powder for oral suspension at 250 mg/5 mL, 500 mg/5 mL and 125 mg/1.25 mL (paediatric), and Clamoxyl-named suspension at 125 mg/5 mL, 250 mg/5 mL and 500 mg/5 mL. The US Drugs@FDA record lists Amoxil for suspension at 125 mg/5 mL, 250 mg/5 mL and 400 mg/5 mL as current. The US label says discard any unused reconstituted suspension after 14 days, with refrigeration preferable but not required. One UK label gives 14 days at 2 to 8 degrees C and another gives 7 days, so shelf life follows the specific holder's label. Confirm the line before ordering.

Amoxil syrup is the oral suspension form of amoxicillin; the EMA annex lists Amoxil Syrup 250 mg/5 mL in Malta as a powder for oral suspension. The UK amoxicillin suspension SmPCs we fetched list acute bacterial sinusitis, acute streptococcal tonsillitis and pharyngitis, acute otitis media, community acquired pneumonia, acute cystitis, acute pyelonephritis, typhoid and paratyphoid fever, dental abscess with spreading cellulitis, Helicobacter pylori eradication and Lyme disease, among others. The US label limits use to susceptible, beta-lactamase-negative isolates in infections of the ear, nose and throat, genitourinary tract, skin and lower respiratory tract. It is contraindicated after a serious hypersensitivity reaction to amoxicillin or other beta-lactams. Dosing is the prescriber's decision and follows the label.

Not as a capsule in the labels we fetched: the UK capsule SmPC covers 500 mg and Drugs@FDA lists Amoxil capsules at 250 mg and 500 mg. The EMA Article 30 referral annex lists Amoxil 1 g dispersible tablets, Amoxil 1 g vials for injection and Amoxil 3 g sachets in the EU, and Clamoxyl 1 g tablets in Spain. The US Amoxil-named tablets in Drugs@FDA are 500 mg and 875 mg, both discontinued in that record. The UK capsule SmPC allows doses of 750 mg to 1 g in several indications. Which 1 g presentation your destination accepts is a registration question, and M Care Exports confirms it per enquiry.

The annex of the 2015 EMA Article 30 referral lists GlaxoSmithKline companies as holders of Amoxil and Clamoxyl in several countries. It lists Beecham Group plc, Brentford, as holder for some Amoxil products, for example in Malta, Lithuania and the UK, and SmithKline Beecham Limited in Cyprus, so the Beecham name appears alongside Amoxil in that listing. In the US, Drugs@FDA lists the current Amoxil products under US Antibiotics, while the GlaxoSmithKline Amoxil entries are marked discontinued. The holder therefore depends on the country, and M Care confirms the current holder per destination.

Yes. In the UK, the SmPCs we fetched come from several holders other than the Amoxil name, and in the US Drugs@FDA lists amoxicillin from several companies under abbreviated (generic) applications. Drugs@FDA shows the current Amoxil-named US capsules and most suspension strengths under abbreviated applications too, with the 400 mg/5 mL suspension under an NDA. M Care also supplies Indian-made lines such as Mox, Cipmox and Almox, which we do not describe as registered anywhere. Co-amoxiclav adds clavulanic acid, a beta-lactamase inhibitor, to amoxicillin, and the two are different products; see the amoxicillin-clavulanate page. We do not recommend one over the other. WHO lists both in the Access group.